½ÃÀ庸°í¼­
»óǰÄÚµå
1584736

¼¼°èÀÇ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÄÄÆ÷³ÍÆ®, À¯Çü, Àü°³, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Ambulatory Software Market by Component, Type, Deployment, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2023³â¿¡ 78¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 85¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.65%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 140¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÎ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î¿¡´Â ¿Ü·¡ ȯÀÚ ¼­ºñ½º¿ëÀ¸·Î ¼³°èµÈ ´Ù¾çÇÑ Apple¸®ÄÉÀÌ¼Ç ¹× ½Ã½ºÅÛÀÌ Æ÷ÇԵ˴ϴÙ. ±× ¹üÀ§¿¡´Â ÀüÀÚ ÀÇ·á ±â·Ï(EHR), Áø·á °ü¸® µµ±¸, ȯÀÚ Æ÷ÅÐ, û±¸ ¼Ö·ç¼Ç µîÀÌ Æ÷ÇԵǸç, ¸ðµÎ º´¿ø ¿ÜºÎÀÇ ¿öÅ© Ç÷οì È¿À², ȯÀÚ °ü¸® ¹× °ü¸® ÇÁ·Î¼¼½º¸¦ °­È­ÇϱâÀ§ÇÑ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒÇÁÆ®¿þ¾îÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ´Â ¹è°æÀ¸·Î´Â ȯÀÚ µ¥ÀÌÅÍ °ü¸®¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí, µðÁöÅÐÈ­¸¦ À§ÇÑ ±ÔÁ¦ÀÇ µÞ¹Þħ, ȯÀÚ Âü¿© Çâ»óÀÇ Çʿ伺, °¡Ä¡ ±â¹Ý ÄÉ¾î ¸ðµ¨·ÎÀÇ À̵¿ µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ Apple¸®ÄÉÀ̼ÇÀº ¼Ò±Ô¸ð °³ÀΠŬ¸®´Ð¿¡¼­ ´ë±Ô¸ð ¿©·¯ Ŭ¸®´Ð¿¡ °ÉÃÄ ¿¹¾à ½ºÄÉÁÙ¸µ, ȯÀÚ ÃßÀû, ¾ÈÀüÇÑ Ä¿¹Â´ÏÄÉÀÌ¼Ç µîÀÇ ±â´ÉÀ» Áö¿øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¿¹Ãø ºÐ¼®À» À§ÇÑ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ¸ð¹ÙÀÏ ÇコÀÇ Áøº¸, »óÈ£ ¿î¿ë¼ºÀÇ Çâ»ó µîÀ» µé ¼ö ÀÖÀ¸¸ç, À̵éÀº »ç¿ëÀÚ °æÇè°ú ¾÷¹« È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, COVID-19ÀÇ À¯Çà¿¡ ÀÇÇØ °¡¼ÓÈ­µÈ ¿ø°Ý ÀÇ·á µµÀÔÀÇ ±ÞÁõÀº ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î Çõ½Å¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº »õ·Î¿î ±âȸ¸¦ ÆÄ¾ÇÇϱâ À§ÇØ µ¥ÀÌÅÍ ºÐ¼® Ȱ¿ë, ¼ÒÇÁÆ®¿þ¾î »óÈ£ ¿î¿ë¼º °­È­, ¿ø°Ý ÀÇ·á ¼Ö·ç¼Ç ĸó¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àü¸Á¿¡µµ ºÒ±¸Çϰí, ½ÃÀåÀº Ãʱ⠵µÀÔ ºñ¿ëÀÇ ³ôÀÌ, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ¿öÅ©Ç÷οìÀÇ È¥¶õ¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡ÀÇ ÀúÇ× µîÀÇ ÇѰ迡 Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ Áؼö´Â ¿©ÀüÈ÷ °úÁ¦À̸ç Áö¿ª¸¶´Ù ´Ù¸£¹Ç·Î ¹ÎøÇϰí ÀûÀÀ¼ºÀÌ ¶Ù¾î³­ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. ºí·ÏüÀÎ ÅëÇÕ, ½Ç½Ã°£ ȯÀÚ ¸ð´ÏÅ͸µÀ» À§ÇÑ IoT µð¹ÙÀ̽º Ȱ¿ë µîÀÌ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. ³»Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ±â¼ú ÅëÇÕ°ú ÇコÄÉ¾î ½Ã½ºÅÛÀÇ ÁøÈ­¿¡ °ßÀεǴ ¿ªµ¿ÀûÀÎ ¼ºÁúÀ» Ư¡À¸·Î Çϸç, »ç¿ëÀÚÀÇ ±â´ë¿Í ±ÔÁ¦ ÄÄÇöóÀ̾𽺿¡ ´ëÀÀÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¾÷µ¥ÀÌÆ®¿Í ±â´É °­È­°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¼º°øÀ» À§Çؼ­´Â ½ÃÀå ÁøÀÔ À庮À» ±Øº¹Çϰí Áö¼ÓÀûÀÎ ¼ºÀåÀ» º¸ÀåÇϱâ À§ÇØ »ç¿ëÀÚ Á᫐ ¼³°è¿Í °ß°íÇÑ Áö¿ø ½Ã½ºÅÛÀ» ¿ì¼±ÇؾßÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 78¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 85¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 140¾ï 5,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 8.65%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¿Ü·¡ ÀÇ·á ¼­ºñ½ºÀÇ °ü¸® Çâ»óÀ» À§ÇÑ µðÁöÅÐÈ­¿Í °¡»óÈ­
    • EHR ÅëÇÕ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î
    • ȯÀÚ ±â·Ï Æ÷ÅÐ °­È­¸¦ À§ÇÑ Á¤ºÎ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÎÇÁ¶ó Á¤ºñ¸¦ Æ÷ÇÔÇÑ µµÀÔ ºñ¿ëÀÇ ³ôÀÌ
  • ½ÃÀå ±âȸ
    • °á°ú¿Í ȯÀÚÀÇ ¾ÈÀü¼º Çâ»óÀ» À§ÇÑ ¿Ü·¡ Áø·á ¿öÅ©Ç÷ο쿡 ´ëÇÑ ÀÓ»ó ÆÇ´Ü Áö¿ø ÅøÀÇ ÅëÇÕ
    • û±¸, Áø·á °ü¸®, ¼öÀÍÁֱ⠰ü¸®ÀÇ ÅëÇÕ
  • ½ÃÀåÀÇ °úÁ¦
    • º¹ÀâÇÑ »óÈ£ ¿î¿ë¼º ¹®Á¦

Porter's Five Forces : ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ ¹× °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼öÀÖ´Â ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¿Ü·¡ ÄÉ¾î ¼­ºñ½ºÀÇ °ü¸® °³¼±À» À§ÇÑ µðÁöÅÐÈ­¿Í °¡»óÈ­
      • EHR ÅëÇÕ ¼ö¿ä Áõ°¡ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î
      • ȯÀÚ ±â·Ï Æ÷ÅÐÀ» °­È­Çϱâ À§ÇÑ Á¤ºÎÀÇ Áö¿øÀû ³ë·Â
    • ¾ïÁ¦¿äÀÎ
      • ÀÎÇÁ¶ó °³¹ßÀ» Æ÷ÇÔÇÑ µµÀÔ ºñ¿ëÀÌ ³ô´Ù
    • ±âȸ
      • ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø ÅøÀ» ¿Ü·¡ Áø·á ¿öÅ©Ç÷ο쿡 ÅëÇÕÇØ, ¼º°ú¿Í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó
      • û±¸, ¾÷¹« °ü¸®, ¼öÀÍÁֱ⠰ü¸®¸¦ ÅëÇÕ
    • °úÁ¦
      • º¹ÀâÇÑ »óÈ£ ¿î¿ë¼º ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¿Ü·¡ÀüÀڰǰ­±â·Ï ¶Ç´Â ÀüÀÚÀÇ·á±â·Ï
  • ¿Ü·¡ ÀÇ·áºñ û±¸
  • ¿Ü·¡ ȯÀÚ Æ÷ÅÐ
  • ¿Ü·¡ Áø·á °ü¸®(PM)

Á¦7Àå ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

  • ¿ÃÀοø ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î
  • ¸ðµâ·¯ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î

Á¦8Àå ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Àü°³º°

  • Ŭ¶ó¿ìµå»ó
  • ¿ÂÇÁ·¹¹Ì½º

Á¦9Àå ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¼ÒÀ¯ÀÇ ¿Ü·¡ ¼¾ÅÍ
  • µ¶¸³ ¿Ü·¡ ¼¾ÅÍ

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿Ü·¡ Áø·á ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • AdvancedMD, Inc.
  • Agfa-Gevaert NV
  • Allscripts Healthcare, LLC
  • Athenahealth, Inc.
  • Change Healthcare Inc.
  • CureMD Healthcare
  • eClinicalWorks, LLC
  • Epic Systems Corporation
  • GE Healthcare
  • Greenway Health, LLC
  • iSALUS, LLC
  • Kareo, Inc. by Tebra Technologies, Inc.
  • NextGen Healthcare, Inc.
  • Updox LLC
BJH 24.11.14

The Ambulatory Software Market was valued at USD 7.86 billion in 2023, expected to reach USD 8.53 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 14.05 billion by 2030.

Ambulatory software, an essential component in healthcare management, encompasses a range of applications and systems designed for outpatient services. Its scope includes electronic health records (EHR), practice management tools, patient portals, and billing solutions, all aimed at enhancing workflow efficiencies, patient care, and administrative processes outside hospital environments. The growing necessity for such software is underscored by increasing patient data management demands, regulatory pushes towards digitization, the need for improved patient engagement, and a shift towards value-based care models. Applications span from small private practices to large multi-specialty clinics, supporting functions like appointment scheduling, patient tracking, and secure communication. Key market growth influencers include the integration of AI and machine learning for predictive analytics, mobile health advancements, and interoperability improvements, which offer opportunities for enhancing user experiences and operational efficiencies. Additionally, the surge in telemedicine adoption, accelerated by the COVID-19 pandemic, presents lucrative opportunities for ambulatory software innovations. Businesses should focus on harnessing data analytics, enhancing software interoperability, and incorporating telehealth solutions to capture emerging opportunities. Despite these prospects, the market faces limitations such as high initial implementation costs, data privacy concerns, and resistance from healthcare professionals due to workflow disruption fears. Furthermore, regulatory compliance remains a challenge, with varying regional mandates necessitating agile and adaptable software solutions. Innovation needs are primarily centered on creating scalable and user-friendly platforms, integrating blockchain for enhanced security, and leveraging IoT devices for real-time patient monitoring. The ambulatory software market is characterized by its dynamic nature, driven by technological integration and healthcare system evolution, demanding continuous updates and enhancements to meet user expectations and regulatory compliance. For success, businesses must prioritize user-centric design and robust support systems to overcome market entry barriers and ensure sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 7.86 billion
Estimated Year [2024] USD 8.53 billion
Forecast Year [2030] USD 14.05 billion
CAGR (%) 8.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ambulatory Software Market

The Ambulatory Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Digitization and virtualization for better management of ambulatory care services
    • Increasing demand of EHR integrated ambulatory software
    • Supportive government initiatives to enhance the patient record portal
  • Market Restraints
    • High cost of deployment including infrastructural developments
  • Market Opportunities
    • Integrating clinical decision support tools into ambulatory care workflows for improved outcomes and patient safety
    • Incorporating billing, practice management, and revenue cycle management
  • Market Challenges
    • Complicated interoperability issues

Porter's Five Forces: A Strategic Tool for Navigating the Ambulatory Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ambulatory Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ambulatory Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ambulatory Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ambulatory Software Market

A detailed market share analysis in the Ambulatory Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ambulatory Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ambulatory Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ambulatory Software Market

A strategic analysis of the Ambulatory Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ambulatory Software Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AdvancedMD, Inc., Agfa-Gevaert N.V., Allscripts Healthcare, LLC, Athenahealth, Inc., Change Healthcare Inc., CureMD Healthcare, eClinicalWorks, LLC, Epic Systems Corporation, GE Healthcare, Greenway Health, LLC, iSALUS, LLC, Kareo, Inc. by Tebra Technologies, Inc., NextGen Healthcare, Inc., and Updox LLC.

Market Segmentation & Coverage

This research report categorizes the Ambulatory Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Ambulatory Electronic Health Record or Electronic Medical Records, Ambulatory Medical Billing, Ambulatory Patient Portal, and Ambulatory Practice Management (PM).
  • Based on Type, market is studied across All-in-One Ambulatory Software and Modular Ambulatory Software.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on End-User, market is studied across Hospital-Owned Ambulatory Centers and Independent Ambulatory Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Digitization and virtualization for better management of ambulatory care services
      • 5.1.1.2. Increasing demand of EHR integrated ambulatory software
      • 5.1.1.3. Supportive government initiatives to enhance the patient record portal
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of deployment including infrastructural developments
    • 5.1.3. Opportunities
      • 5.1.3.1. Integrating clinical decision support tools into ambulatory care workflows for improved outcomes and patient safety
      • 5.1.3.2. Incorporating billing, practice management, and revenue cycle management
    • 5.1.4. Challenges
      • 5.1.4.1. Complicated interoperability issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ambulatory Software Market, by Component

  • 6.1. Introduction
  • 6.2. Ambulatory Electronic Health Record or Electronic Medical Records
  • 6.3. Ambulatory Medical Billing
  • 6.4. Ambulatory Patient Portal
  • 6.5. Ambulatory Practice Management (PM)

7. Ambulatory Software Market, by Type

  • 7.1. Introduction
  • 7.2. All-in-One Ambulatory Software
  • 7.3. Modular Ambulatory Software

8. Ambulatory Software Market, by Deployment

  • 8.1. Introduction
  • 8.2. On-Cloud
  • 8.3. On-Premise

9. Ambulatory Software Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospital-Owned Ambulatory Centers
  • 9.3. Independent Ambulatory Centers

10. Americas Ambulatory Software Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Ambulatory Software Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Ambulatory Software Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. AdvancedMD, Inc.
  • 3. Agfa-Gevaert N.V.
  • 4. Allscripts Healthcare, LLC
  • 5. Athenahealth, Inc.
  • 6. Change Healthcare Inc.
  • 7. CureMD Healthcare
  • 8. eClinicalWorks, LLC
  • 9. Epic Systems Corporation
  • 10. GE Healthcare
  • 11. Greenway Health, LLC
  • 12. iSALUS, LLC
  • 13. Kareo, Inc. by Tebra Technologies, Inc.
  • 14. NextGen Healthcare, Inc.
  • 15. Updox LLC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦